We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Molecular Test Improves Diagnosis of Human Babesiosis

By LabMedica International staff writers
Posted on 18 Jan 2017
Print article
Image: Babesia microti in a thin blood smear stained with Giemsa (Photo courtesy of Spencer S. Eccles Health Sciences Library).
Image: Babesia microti in a thin blood smear stained with Giemsa (Photo courtesy of Spencer S. Eccles Health Sciences Library).
Babesia species are tick-borne apicomplexan parasites that infect erythrocytes and several species including B. microti, B. duncani, B. venatorum, B. divergens and B. divergens-like organisms can infect humans.

Babesia infections often are asymptomatic but immunocompromised individuals and even some immunocompetent persons can experience serious, life-threatening manifestations such as splenic rupture, respiratory distress or renal failure. Asymptomatic infected blood donors often are unaware of their infections.

Medical microbiologists and their colleagues at the University of Washington obtained B. microti-containing whole blood samples and negative whole blood samples from de-identified leftover EDTA-anticoagulated clinical samples. The team developed one-step reverse transcription polymerase chain reaction (RT-PCR) for B. microti 18S ribosomal ribonucleic acid (rRNA) as a diagnostic test to take advantage of the biological enrichment of B. microti 18S rRNA as compared to 18S rDNA. This general approach can in future be applied to other Babesia species as well for species specific or pan-Babesia 18S rRNA detection.

Babesia 18S rRNA RT-PCR was performed on an m2000 RealTime System. Nominal densities of B. microti-infected blood samples used for standard curves were measured by counting Giemsa-stained blood smears by microscopy (number of parasites per 2,000 erythrocytes). B. microti-specific primer/probe set was optimized for RT-PCR to generate a highly efficient reaction capable of sub-microscopic B. microti detection.

The assay detected B. microti 18S rRNA in 11 of 11 samples from patients with active or recent B. microti infections. The RT-PCR could detect some samples that may be missed by a PCR-only approach. B. microti 18S rRNA is over 1,000-fold more abundant than its coding genes, making reverse transcription PCR (RT-PCR) much more sensitive than PCR. There was no cross-reactivity against five uninfected blood samples or two high-density Plasmodium falciparum-infected blood samples.

The authors concluded that molecular screening tests for B. microti should be able to detect a single organism in a test volume of ~50–500 μL of whole blood to provide an ultrasensitive limit of detection for use in blood product testing. This limit of detection can likely be achieved using a RT-PCR-based approach and therefore may be useful for screening the blood supply. The study was published on December 5, 2016, in the journal Diagnostic Microbiology and Infectious Disease.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.